Latest News
Read the latest news releases and announcements from Par Health.
Par Health Launches Sugammadex Injection in Manufacturer-Prepared, Ready-to-Use Prefilled Syringe
Par Health Launches First and Only Generic Version of Janumet® XR (sitagliptin and metformin HCl extended-release) Tablets in the United States
Par Health Names Norv McAndrew as EVP, Chief Legal Officer and Corporate Secretary
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables
Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
Investor Information
Media Contact
For questions or comments, reach our Media Relations team here.